產(chǎn)品詳情
Cat#:143P67
序列(三字母):Phenylac-Leu-Asp-Phe-D-Pro-NH?
序列(單字母):Phenylac-LDFp-NH?
類似名:VLA-4 Inhibitor
分子式:C??H??N?O?
分子量:607.71
CAS#:209601-16-1
合成方法:Synthetic
存儲條件:-20 ± 5 °C
應(yīng)用:Adhesion Molecules & Extracellular Matrix Proteins
描述:This connecting segment-1 (CS1) peptide blocked the binding of the very late antigen-4 (VLA-4) integrin to fibronectin and thereby it reduced accelerated coronary arteriopathy in rabbit cardiac allografts. Thus, this therapeutic approach might be useful either in preventing the development or limiting the severity of graft arteriopathy after cardiac transplantation.
1)通過電話(+86-(0)-18115476705)郵件([email protected])聯(lián)系我們;
2)提供合成多肽的具體需求,包括序列、質(zhì)量和純度,技術(shù)部門評估后給與報價。
3)簽訂多肽合成合同,交付合成預付款,科研機構(gòu)先使用再付款!
4)合成過程定期跟您匯報合成進度及情況;
5)根據(jù)合同內(nèi)容,隨貨提供發(fā)票;
6)如因本公司原因不能交貨或合成失敗,退還所有合成款!
Copyright ?2020 南京肽谷生物科技有限公司 備案號:蘇ICP備19062824號-1 網(wǎng)站地圖